Literature DB >> 17702074

Total synthesis of (+/-)-gamma-rubromycin on the basis of two aromatic Pummerer-type reactions.

Shuji Akai1, Keisuke Kakiguchi, Yuka Nakamura, Ikumi Kuriwaki, Toshifumi Dohi, Shusaku Harada, Ozora Kubo, Nobuyoshi Morita, Yasuyuki Kita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17702074     DOI： 10.1002/anie.200702382

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN： 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  6 in total

Review 1.  Human telomerase inhibitors from microbial source.

Authors:  Kalarikkal Gopikrishnan Kiran; Muthusamy Palaniswamy; Jayaraman Angayarkanni
Journal:  World J Microbiol Biotechnol       Date:  2015-07-01       Impact factor: 3.312

2.  Stereoselective synthesis of benzannulated spiroketals: influence of the aromatic ring on reactivity and conformation.

Authors:  Guodong Liu; Jacqueline M Wurst; Derek S Tan
Journal:  Org Lett       Date:  2009-08-20       Impact factor: 6.005

3.  Structure Determination, Functional Characterization, and Biosynthetic Implications of Nybomycin Metabolites from a Mining Reclamation Site-Associated Streptomyces.

Authors:  Xiachang Wang; Sherif I Elshahawi; Larissa V Ponomareva; Qing Ye; Yang Liu; Gregory C Copley; James C Hower; Bruce E Hatcher; Madan K Kharel; Steven G Van Lanen; Qing-Bai She; S Randal Voss; Jon S Thorson; Khaled A Shaaban
Journal:  J Nat Prod       Date:  2019-12-13       Impact factor: 4.050

4.  Facile synthesis of naphthoquinone spiroketals by diastereoselective oxidative [3 + 2] cycloaddition.

Authors:  Kun-Liang Wu; Stephanie Wilkinson; Norbert O Reich; Thomas R R Pettus
Journal:  Org Lett       Date:  2007-11-29       Impact factor: 6.005

5.  Solvent-dependent divergent functions of Sc(OTf)₃ in stereoselective epoxide-opening spiroketalizations.

Authors:  Indrajeet Sharma; Jacqueline M Wurst; Derek S Tan
Journal:  Org Lett       Date:  2014-04-17       Impact factor: 6.005

6.  Computational development of rubromycin-based lead compounds for HIV-1 reverse transcriptase inhibition.

Authors:  Carlos E P Bernardo; Pedro J Silva
Journal:  PeerJ       Date:  2014-07-10       Impact factor: 2.984
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.